Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy
Elizabeth Packard, Alejandro de Feria, Supriya Peshin, et al.
Cardiology and Therapy (2022) Vol. 11, Iss. 4, pp. 491-507
Open Access | Times Cited: 19

Showing 19 citing articles:

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
M. Litt, Ayan Ali, Nosheen Reza
Vascular Health and Risk Management (2023) Vol. Volume 19, pp. 211-221
Open Access | Times Cited: 16
Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Sneha Annie Sebastian, Inderbir Padda, Eric J. Lehr, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 5, pp. 519-532
Closed Access | Times Cited: 12
Recent Clinical Updates of Hypertrophic Cardiomyopathy and Future Therapeutic Strategies
Mengya Zhao, Xianzhen He, Xinwen Min, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access
Evolution of genetic testing and gene therapy in hypertrophic cardiomyopathy
Katherine Chiswell, Louisa Zaininger, Christopher Semsarian
Progress in Cardiovascular Diseases (2023) Vol. 80, pp. 38-45
Closed Access | Times Cited: 9
Proline metabolic reprogramming modulates cardiac remodeling induced by pressure overload in the heart
Qingbo Lv, Duanbin Li, Liding Zhao, et al.
Science Advances (2024) Vol. 10, Iss. 19
Open Access | Times Cited: 2
Hypertrophic Cardiomyopathy: Current Treatment and Future Options
Sneha Annie Sebastian, Venkatesh Panthangi, Karanbir Singh, et al.
Current Problems in Cardiology (2022) Vol. 48, Iss. 4, pp. 101552-101552
Closed Access | Times Cited: 11
Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement
Anna Burban, Szymon Pucyło, Aleksandra Sikora, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13239-13239
Open Access | Times Cited: 5
An overview of the treatments for hypertrophic cardiomyopathy
Wenna Xu, Fuyu Zhu, Yue Zhang, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy
Gabriella Captur, Ivan Doykov, Sheng‐Chia Chung, et al.
Circulation Genomic and Precision Medicine (2024) Vol. 17, Iss. 3
Open Access | Times Cited: 1
Modern Perspectives on Hypertrophic Cardiomyopathy—No One Size Fits All
Brett Doliner, Hadeel Gaddar, Ramsey Kalil, et al.
Texas Heart Institute Journal (2024) Vol. 51, Iss. 2
Open Access | Times Cited: 1
Comparing the efficacy and safety of medications in adults with hypertrophic cardiomyopathy: a systematic review and network meta-analysis
Keying Mi, Sijia Wu, Chanyuan Lv, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
A case report of PIMSRA (percutaneous intramyocardial septal radiofrequency ablation) in an adult with re-obstruction after Morrow procedure
H.C. Wang, Changhui Lei, Liwen Liu
European Heart Journal - Case Reports (2024) Vol. 8, Iss. 4
Open Access
Nuevos tratamientos farmacológicos para la miocardiopatía hipertrófica: foco en inhibidores de miosina
Felipe Norambuena, Jorge Jalil
Revista chilena de cardiología (2024) Vol. 43, Iss. 1, pp. 55-63
Open Access
Multi-Faceted Approach to Ventricular Tachycardia: A Review of Management Strategies
Francis Hartge, Jamario Skeete, A. Bodas Pinedo, et al.
Pharmacoepidemiology (2024) Vol. 3, Iss. 3, pp. 265-284
Open Access
Optimal Medical Therapy Versus Septal Reduction Therapy
Francis Joshua Beloy, Jillian Reeze Medina, Ralf Martz Sulague, et al.
JACC Advances (2024) Vol. 4, Iss. 1, pp. 101412-101412
Open Access
Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Fernando Saraiva, Fábio Fernandes, Minna Moreira Dias Romano, et al.
ABC Heart Failure & Cardiomyopathy (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Pharmacotherapy for hypertrophic cardiomyopathy
Г. А. Игнатенко, Г. Г. Тарадин, L. V. Kononenko
South Russian Journal of Therapeutic Practice (2023) Vol. 4, Iss. 4, pp. 6-13
Open Access | Times Cited: 1
Surgical myectomy in patients with obstructive hypertrophic cardiomyopathy and concomitant cardiac diseases
Г. Г. Тарадин, E.B. Solovyov, Г. А. Игнатенко, et al.
Russian Journal of Cardiology and Cardiovascular Surgery (2023) Vol. 16, Iss. 3, pp. 297-297
Closed Access
Bicuspid aortic valve with associated aortopathy, significant left ventricular hypertrophy or concomitant hypertrophic cardiomyopathy: A diagnostic and therapeutic challenge
Ivana Sopek Merkaš, Nenad Lakušić, Mladen Predrijevac, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 18, pp. 4251-4257
Open Access
Page 1

Scroll to top